FDA Approves Generic Version of Xalatan® Eye Drops for Glaucoma

April 4, 2011

Mylan Inc. today announced that the FDA has approved its Latanoprost Ophthalmic Solution, 0.005%, a generic version of Xalatan® eye drops for treatment of glaucoma.

The product represents Mylan’s first ophthalmic solution.

Click here for the full press release.




Jump down to form below to submit your own comments

Comments are closed.